Learn more

UCHREZHDENIE ROSSIJSKOJ AKADEMII NAUK INST BIOORG KHIM IM AKADEMIKOV M M SHEMJAKINA I JU A OVCHINNIK

Overview
  • Total Patents
    40
About

UCHREZHDENIE ROSSIJSKOJ AKADEMII NAUK INST BIOORG KHIM IM AKADEMIKOV M M SHEMJAKINA I JU A OVCHINNIK has a total of 40 patent applications. Its first patent ever was published in 2008. It filed its patents most often in Russian Federation and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are SHANGHAI BIOWINDOW GENE DEV, CODIAK BIOSCIENCES INC and BODE GENE DEV CO LTD SHANGHAI.

Patent filings in countries

World map showing UCHREZHDENIE ROSSIJSKOJ AKADEMII NAUK INST BIOORG KHIM IM AKADEMIKOV M M SHEMJAKINA I JU A OVCHINNIKs patent filings in countries

Patent filings per year

Chart showing UCHREZHDENIE ROSSIJSKOJ AKADEMII NAUK INST BIOORG KHIM IM AKADEMIKOV M M SHEMJAKINA I JU A OVCHINNIKs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Grishin Evgenij Vasil Evich 7
#2 Buzdin Anton Aleksandrovich 7
#3 Alekseev Boris Jakovlevich 6
#4 Zabolotneva Anastasija Aleksandrovna 6
#5 Gajfullin Nurshat Minullaevich 6
#6 Shegaj Petr Viktorovich 6
#7 Rusakov Igor Georgievich 6
#8 Valjakina Tat Jana Ivanovna 5
#9 Miroshnikov Anatolij Ivanovich 5
#10 Komaleva Ravilja Ljukmanovna 5

Latest patents

Publication Filing date Title
RU2474426C1 Prostamides and their analogues possessing neuroprotective action
RU2469098C2 Method for estimating clinical effectiveness of human bladder cancer by real-time pcr and kit for implementation thereof
RU2468372C1 Method of estimating efficiency of therapy of urinary bladder cancer by means of oncomarker nusap1
RU2463354C1 Diagnostic technique for bladder cancer by cancer-specific marker tedp1 (versions) and kit for implementing it
RU2468088C1 Method of estimating efficiency of therapy urinary bladder cancer in humans by method of immunofermentative analysis
RU2470301C2 Method of diagnosing urinary bladder cancer by means of oncomarker kifc1 (versions) and set for its realisation
RU2453599C1 NUCLEIC ACID CODING FUNCTIONALLY ACTIVE RECOMBINANT IgAL PROTEASE NEISSERIA MENINGITIDIS OF SEROGROUP B, RECOMBINANT PLASMID DNA CONTAINING NUCLEOTIDE SEQUENCE CODING ACTIVE IgAL PROTEASE, PRODUCER STRAIN CONTAINING PLASMID DNA PRODUCING MATURE FORM OF IgAL PROTEASE, RECOMBINANT Ig PROTEASE NEISSERIA MENINGITIDIS OF SEROGROUP B, METHOD FOR PRODUCING MATURE FORM IgAL PROTEASE SHOWING IMMUNOGENIC AND PROTECTIVE PROPERTIES
RU2455359C1 Peptide having high affinity to type alpha7 human nicotinic receptor and use thereof
RU2469323C2 Diagnostic technique for bladder cancer (versions) and kit for implementation thereof
RU2447150C1 Agent for gene therapy of malignant growths
RU2429005C1 Method of stimulating anti-tumour activity of cytotoxic effectors of immune system
RU2429008C1 METHOD OF PURIFICATION OF HUMAN RECOMBINANT GROWTH FACTOR VIIa
RU2445768C1 Method for obtaining genetically modified plants of kalanchoe, expressing gene of cecropin p1
RU2422459C1 Peptide purinoceptor modulator
RU2422516C1 Mouse hybridoma s79 - producer of monoclonal antibody showing specificity to human nucleolus protein surf-6
RU2430966C1 Bacterial peptide antibiotic laterocin for inhibiting growth of microalgae
RU2421514C1 Mouse hybridone s148-producer of monoclonal antibody to nucleolar protein surf-6 of mammals
RU2413769C1 RECOMBINANT PLASMID DNA pET-32a, CODING GEN LIGNAD-BINDING DOMAIN OF RECEPTOR II TYPE OF HUMAN TRANSFORMING GROWTH FACTOR-β (TβRII), STRAIN OF BACTERIA Escherichia coli - PRODUCENT OF FUSION PROTEIN THIOREDOXIN/TβRII AND METHOD OF RENATURATION AND PURIFICATION OF TARGET PROTEIN TβRII
RU2408604C1 LanA2 PEPTIDE ISOLATED FROM BACILLUS LICHENIFORMIS VK21 BACTERIA, HAVING ANTIMICROBIC ACTION
RU2408732C1 PEPTIDE LanA1, EXTRACTED FROM Bacterium bacillus LICHENIFORMIS VK21, HAVING ANTIMICROBIAL EFFECT